Form 4 Tracker
Richard R. Deluca

EVP&Pres, Merck Animal Heallth · 4 filings · Latest: May 5, 2026

Merck & Co., Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthApr 29, 2026
Option Exercise
$110.032,518$277.1K162,778.07
MRK
RICHARD ROBERT DELUCA JR.Feb 6, 2026
Proposed Sale
$120.9237,685$4.6M
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthFeb 6, 2026
Sale
$120.9237,685$4.6M160,173.834